PDS Biotechnology Corp (PDSB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $107.07M
Last updated: Nov 17, 2026 at 11:05 AM ET
PDS Biotechnology Corp (PDSB) Stock Forecast
Analysts expect PDS Biotechnology (PDSB) to earn -$0.43 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.19.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$0.43
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.19
- EPS consensus, revenue $9.38M
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.43 | -$0.49 to -$0.37 | 2 | N/A | N/A | 2 |
| Dec 31, 2027 | -$0.19 | -$0.30 to -$0.08 | 2 | $9.38M | N/A | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.09 | -$0.09 to -$0.09 | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.50.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.43 | -$0.49 | -$0.49 | -$0.46 | -$0.50 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.19 | -$0.35 | -$0.36 | -$0.37 | -$0.47 | N/A |
Frequently Asked Questions About PDSB
What is the PDSB stock forecast?
Consensus analyst estimates put PDS Biotechnology's EPS at -$0.43 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from PDSB next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.43, with estimates from -$0.49 to -$0.37 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.19, with estimates from -$0.30 to -$0.08 from 2 analysts.
What revenue do analysts expect from PDS Biotechnology next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.38M.
How many analysts cover PDSB?
2 analysts estimate EPS for PDS Biotechnology for the fiscal year ending Dec 31, 2026.
PDSB pages: Overview, Earnings, Forecast, Financials, Competitors